Big ideas and little changes – our CEO shares renewed ambition to change lives today and tomorrow

A future free from arthritis and the impact of arthritis has been the driving force behind Arthritis Research UK since we first began 80 years ago.In 2016 we remain focussed on the future, continuing our multi-million-pound investment in exceptional science, but we’re also evolving to ensure we meet the needs of people with arthritis right now and transform lives today.We asked our Chief Executive Officer Dr Liam O’Toole to share with you how we’re broadening our scope and ambitions and, most importantly, how these little changes to our approach will help everybody live fuller lives with arthritis today and without it tomorrow.Can you tell us what’s new at Arthritis Research UK?"Over the last two years we’ve talked to thousands of people with arthritis, listened carefully to what you’re telling us and used your experiences to inform our plans and determine where we invest our energy and resources. Our new approach is for you and it’s also down to you."The valuable insight you’ve given us demanded we broaden our scope. It’s driving everything we do and making us the organisation we need to be."We’re still investing in the big ideas. In the last year alone we’ve made£21 million of new research grant commitments, funding the groundbreaking research needed to unearth new and effective treatments, early diagnosis and a cure. But we’re also working hard to find solutions to the challenges that limit every...
Source: Arthritis Research UK - Category: Rheumatology Source Type: news